Less Than First: Below-Average Innovation In US FDA’s Big 2023 Novel Approval Haul

 
• By Bridget Silverman
  
below average
The US FDA approval class of did not get strong marks in some areas. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews